AI Could Improve Prostate Cancer Brachytherapy
Enhanced deep-learning models have the potential to streamline prostate cancer brachytherapy treatment planning, according to investigators.
PROSTATE CANCER ADVISOR
Prostate Cancer
Features
-
-
Imaging Needed to Identify Bone Metastases in Advanced PCa
Bone imaging cannot be safely omitted in advanced prostate cancer cases because no PSA level combined with T stage and Gleason Grade Group can accurately rule in bone metastases, a new study found. -
Optimal mCRPC Drug Sequences Emerging
Recent studies provide guidance on which drugs should be used first to obtain the best outcomes. -
Kegel Exercises After Prostate Surgery Called Into Question
Pelvic physical therapy may be more appropriate than Kegel exercises in managing post-radical prostatectomy pain and stress urinary incontinence, according to a new study. -
Novel Antiandrogens and Cognitive Function
The authors of a recent review say they believe only a fraction of the men on androgen receptor-directed therapies who experience cognitive impairment report it. -
Study Identifies Racial Differences in Prostate Cancer Gene Expression Tests
Commercially available gene expression tests for predicting prostate cancer progression appear to be less accurate in black vs white men, according to a new study. -
Multidisciplinary Prostate Cancer Clinics May Promote Optimal Care
Receiving prostate cancer care at multidisciplinary clinics facilitates adherence to evidence-based national guidelines and potentially ameliorates bias in treatments, a study found.
Latest Prostate Cancer News
10-Year Outcomes Similar for H-IMRT, C-IMRT in Prostate Cancer
10-year cumulative incidence of biochemical and/or clinical disease failure no different with C-, H-IMRT.
Exploring the DNA Methylome in mCRPC Through NGS of Plasma DNA Specimens
An understanding of the tumor methylome can provide information on gene regulation in different cancers.
Prostate MRI Improves Confirmatory Biopsy Sensitivity
MRI-guided confirmatory prostate biopsies more accurately detects grade progression among men on active surveillance for prostate cancer compared with TRUS-guided systematic biopsies alone.
Radium-223 Effects on Bone Marrow May Be More Serious Than Previously Reported
In a small study, pancytopenia induced by radium-223—which is used to treat bone metastases in men with metastatic castration-resistant prostate cancer— developed more frequently reported in the pivotal phase 3 trial of the drug.
Salvage Radiotherapy Called a Viable Option for Recurrent Prostate Cancer
The authors of new review say the results of the JCOG0401 trial suggest that standard hormonal therapy alone vs salvage radiotherapy is not an appropriate management strategy for recurrence after radical prostatectomy.
Docetaxel Use in High-Risk Prostate Cancer: New Long-Term Data
There was a small beneficial effect of adding docetaxel to androgen suppression and radiotherapy, a follow-up study showed.
ADT Use for Prostate Cancer Increases Anemia Risk
Treatment with androgen deprivation therapy alone is associated with increased risks for anemia compared with radical prostatectomy alone, a study found.
Combining MRI-Targeted, Systematic Biopsy Appears Best for PCa Detection
In a study, 8.8% of clinically relevant prostate cancers detected by systematic biopsy were missed by MRI-targeted biopsy.
Canned, Cooked Tomatoes May Cut Prostate Cancer Risk
Consumption of canned and cooked tomatoes may be associated with a decreased risk of prostate cancer (PCa), according to investigators. A prospective study of 27,934 Adventist men free of cancer at enrollment found that consumption of canned and cooked tomatoes 5 to 6 times a week was significantly associated with a 28% decreased risk of…
New Study Supports PSA-Stratified Prostate Cancer Screening
Less intensive PSA screening in men with low PSA levels can substantially reduce unnecessary testing, according to investigators.
Want to read more?
Please login or register first to view this content.
Next post in Prostate Cancer
